EFDID: 66415EFD: View Filing

Issuer: Trevi Therapeutics, Inc. (0001563880) - D

Accession: 0001563880-12-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001563880
  • Entity Name:
    Trevi Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2011)
  • Address:
    52 Charter Ridge Road
    Sandy Hook, CT 06482
  • Persons:
    Related Persons 5
    Jennifer L. Good
    Executive OfficerDirector
    Eran Nadav
    Director
    Cayce Denton
    Director
    Thomas R. Sciascia
    Executive Officer
    Joseph Sorrentino
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    12/18/2012
  • First Sale Date:
    12/05/2012
  • Offering Amount:
    $13,064,102
  • Amount Sold:
    $6,564,102
  • Amount Remaining:
    $6,500,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Trevi Therapeutics, Inc./s/ Jennifer L. GoodJennifer L. GoodPresident and Chief Executive Officer2012-12-18